throbber
Handbook of
`
`PHARMACEUTICAL
`
`EXCIPIENTS
`
`Second Edition
`
`Edited by
`Ainley Wade and Paul J Weller
`
`The Pharmaceutical Press
`
`Mylan v. Qualicaps, IPR2017-00203
`QUALICAPS EX. 2003 - 1/7
`
`

`

`© Copyright 1986, 1994 by the American Pharmacetttical Association, 2215 Constitution Avenue NW, Washington,
`DC 2003?-2985, USA, and The Pharrnacetitical Press. Royal Phartnaceutical Society of G1'eat Britain, 1 Lambeth High
`Street, London, SE1 TJN, Engiand.
`
`A catalogue record for this book is available from the British Library.
`
`Library of Congress Catalog Card Number: 94—?94‘)2.
`
`International Standard Book Number (ISBN) in the UK: 0 85369 305 6
`International Standard Book Number (ISBN) in the USA: 0 9l?3() 66 8
`
`No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical,
`including photocopy, recording, or any information storage or retrieval system, without prior written permission from
`the joint publishers.
`
`Typeset in Great Britain by Alden Multimedia, Northampton.
`Printed and bound in Great Britain by
`
`M Ian V. Qualicas |PR2017-00203
`
`Mylan v. Qualicaps, IPR2017-00203
`QUALICAPS EX. 2003 - 2/7
`
`

`

`Hydroxypropyl
`Methylcellulose
`
`l. Nonproprietary Names
`BP: Hypromellose
`PhEur: Methylhydroxyptopylccllulosum
`USP: Hydroxypropyl methylcellulose
`
`2. Synonyms
`Cellulose,
`ltydroxypropyl methyl ether; Ca.-’.In.umt' MHPC;
`E464; HPMC;
`:".a‘r>rhocc'l; methyleellulose propylene glycol
`ether; methyl hydroxyptopylcellulose; Mr’tot"o.s'c=; P!'a::i‘iimcori.'.
`
`3. Chemical Name and CAS Registry Number
`Cellulose, 2-Hydroxypropyl methyl ether
`[90i]4—65—3]
`
`4. Empirical Formula Molecular Weight
`The PhE1Ir I992 describes hydroxypropyl methylcellulose as a
`partly 0—methylated and O-(2-hydroxypropylated) cellulose.
`It
`is available in several grades which vary in viscosity and
`extent of substitution. Grades may be distinguished by
`appending a number indicative of the apparent viscosity,
`in
`mPa s, ofa 2% vvfw aqueous solution at 20"C. Hydroxypropyl
`methylcellulose defined in the USP XXII
`specifies
`the
`substitution type by appending a four digit number to the
`nonproprietary name, c.g. hydroxypropyl methylcellulose
`I828. The first two digits refer to the approximate percentage
`content of the methoxy group (OCH3). The second two digits
`refer to the approximate percentage content of the hydroxy-
`propoxy group (OCI-I;CHOHCH3}t calculated on a dried
`basis. Molecular weight is approximately 10000-l 500 000.
`
`5. Structural Formula
`
`CH,0R
`
`or:
`
`0
`
`o
`
`D
`
`on
`
`OR
`
`0R
`
`0
`
`cH,ok
`
`Where R is H. CH3 or [CH3CH(OH)CH3].
`
`6. Functional Category
`Coating agent:
`lilm—former; stabilizing agent; suspending
`agent; tablet binder; viscosity—increasing agent.
`
`h"_1-'dn:_r_ij;u'r)p_t-'1’ 391:3f»iiyt'('eH'rrItJ.\'c
`
`229
`
`In oral products, hydroxypropyl melhylccllulose is primarily
`used as a tablet binder," in lilm-c0ating‘3'7' and as an
`extended release tablet r11atrix.‘"'”’ Concentrations of between
`2-5"/1: W,-‘W may he used as a binder in either wet or dry
`granulation processes. High viscosity grades may be used to
`retard the release ol‘ water—solul:-le drugs from a matrix.
`Depending upon the viscosity grade, concentrations between
`2—t0% wfw are used as film-forming solutions to film-coat
`tablets. Lower viscosity grades are used iI1 aqueous film-
`coating solutions while higher viscosity grades are used with
`organic solvents.
`Hydroxypropyl methylcellulose is also used as a suspending
`and thickening agent
`in topical
`formulations, particularly
`ophthalmic preparations. Compared with mcthylecllulose,
`hydroxypropyl irtethylccllulose produces solutions of greater
`clarity, with fewer undispersed fibres present, and is therefore
`prel'erred in fortnulations for ophthalmic use. Concentrations
`of between 0.45-l.{)% wfw may be added as a thickening agent
`to vehicles for eye-drops and artificial tear soiutions.
`Hydroxypropyl methylcellulose is also used as an emulsifier,
`suspending agent and stabilizing agent
`in topical gels and
`ointments. As a protective colloid, it can prevent droplets and
`particles from coalescing or agglomerating, thus inhibiting the
`formation of sediments.
`
`ln addition, hydroxypropyl mcthylcellulose is used as an
`adhesive in plastic bandages and as a wetting agent for hard
`contact lenses. It is also widely used in cosmetics and food
`products.
`
`8. Description
`I-lydroxypropyl rrtethylcellulose is an odorless and tasteless,
`white or creamy-white colored fibrous or granular powder.
`
`9. Pharmaeopeia! Specifications
`Test
`PhEur 1992
`
`Identification
`Appearance of solution
`pH (1% wfw solution)
`Apparent viscosity
`Loss on drying
`Residue on ignition
`for viscosity grade > 50 mPa s
`for viscosity grade 5c 50 mPa s
`for type [828 of all viscositics
`Sulfated ash
`
`Arsenic
`ChloI'idcs
`Heavy metals
`Mcthoxy content
`Type 1828
`Type 2208
`Type 2906
`Type 2910
`Hydroxypropoxy content
`Type [828
`Type 2208
`Type 2906
`Type 2910
`
`.
`
`.
`
`$ 5.0%
`
`5,
`l.5%
`=.-’~. 3.0%
`:4, 5.0%
`-
`
`-as 3 ppm
`—
`S, fl.00| %
`
`16.5-20.0%
`I91}-24.0%
`2'l'.t}—3t].I]%
`23.0-3t].D“/o
`
`23.0~32.0%
`4.0-l2.t}“/u
`4.0-1.5%
`7.{l—l2.0‘3/o
`
`Tr‘. Applications in Pharmaceutical Formulation or
`Technology
`tnethylcellulose is widely used in oral and
`Hydroxypropyl
`topical pharmaceutical Forinulatioiis.
`
`10. Typical Properties
`A ctr!!!)rfrrikrrlfirfry-':
`pH = 5.5-8.0 for a l% wfvv aqueous solution.
`
`Mylan v. Qualicaps, |PR2017—OO203
`
`Mylan v. Qualicaps, IPR2017-00203
`QUALICAPS EX. 2003 - 3/7
`
`

`

`230 Hydro.\‘ypropyt' Metliyiceflttlose
`
`SEM: 1
`Eitcipient: Hydroxypropyl methylcellulose
`Manufacturer: Shin-Etsu Chemical Co Ltd
`Lot No.: 832M
`Magnification: 60::
`voltage: lDkV
`
`.
`
`'
`
`SEM: 2
`Excipienl: Hydroxypropyl mctliylccllulosc
`Manufacturer: Shin-Etsu Cliemicul Co Ltd
`Lot No.: 33214
`Magnification: tatlflx
`
`Vomgc: mkv
`
`Ash: 1.5-3.0%, depending upon the grade.
`Atttoigiifrioii tempcrariu'e: 360°C
`Density (tamiedj: 0.50-0.70 g;'cm3 for P.-'mi'mrrcont.
`Melting point: browns at 190-200°C; cha1's at 225-230°C. Glass
`transition temperature is I70-180°C.
`Moi.rf:tt'e content: hydroxypropyl methylcellulose absorbs
`moisture from the atmosphere, the amount of water absorbed
`depending upon the initial moisture content and the
`temperature and relative humidity of the surrounding air.
`See n.-‘so HPE Data.
`
`Soiubi.iit_v: soluble in cold water, forming a viscous colloidal
`solution; practically insoluble in chloroform, ethanol (95%)
`and ether, but soluble in mixtures of ethanol and dichlor-
`ornethane. and mixtures of methanol and dichloromethane.
`Certain grades of hydroxypropyl methylcellulose are soluble in
`aqueous acetone solutions, mixtures of dichlorornethane and
`propan-2-ol. and other organic solvents. See also Section II.
`Specific g.t'm=i.[i=: 1.26
`Vl".S'IE‘tJ'.t‘fl‘_]'
`(dynmm'c): a wide range of viscosity types are
`commercially available. Aqueous solutions are most corn-
`monly prepared although hydroxypropyl methyleellutose may
`also be dissolved in aqueous alcohols such as ethanol and
`propan—2~o| provided the alcohol content is less than 50% tvfw.
`Dichloromethane and ethanol mixtures may also be used to
`prepare viscous hydroxypropyl
`inethylcellulose solutions.
`Solutions p1'epared using organic solvents tend to be more
`viscous; increasing concentration also produces more viscous
`solutions, see Table I.
`recoinmended that
`is
`it
`To prepare an aqueous solution,
`hydroxypropyl nlethylcellulose is dispersed and thoroughly
`hydrated in about 20-30% of the required amount of water.
`The water should be vigorously stirred and heated to 80-90°C
`then the remaining hydroxypropyl ntethylcellulose added.
`Cold water should then be added to produce the required
`volume.
`When a water—miscible organic solvent such as ethanol. glycol.
`or mixtures of ethanol and dichloromethane is used,
`the
`hydroxypropyl methylcellulose should first be dispersed into
`the organic solvent, at a ratio of 5-8 parts of solvent to 1 part
`of hydroxypropyl methylceilulose. Cold water is then added to
`produce the required volume.
`
`Table 1: Dynamic viscosity (mPa s) of Phummcom 603 {Shin-Etsu
`Chemical Co Ltd) solutions in various solvents at 20"'C.
`
`Solvent
`
`Viscosity (mPa 5) at }.'l}"C
`Concentration (‘l/n nftv}
`2
`6
`10
`14
`
`Dichloromethane: ethanol (50:50)
`Ethanol: water (50:50)
`Water
`
`4
`8
`3
`
`28
`32
`I5
`
`I50
`I20
`45
`
`580
`350
`I00
`
`Moisture content
`Moisture content
`Moisture content
`
`HPE Laboratory Project Data
`Method
`Lab #
`Results
`
`MC-20
`MC—20
`EMC-l
`
`I5
`I5
`IS
`
`_
`
`2.It)% “"
`3.|tJ"/a ”"
`See Fig.
`
`I. ""’
`
`Supplier: a. Dow Chemical Company; b. Aqua Ion.
`
`11. Stability and Storage Conditions
`Hydroxypropyl methylcellulose powder is a stable material
`allliough it is hygroscopic after drying.
`
`Mylan v. Qualicaps, |PR2017—OO203
`
`Mylan v. Qualicaps, IPR2017-00203
`QUALICAPS EX. 2003 - 4/7
`
`

`

`
`
`
`
`Percentequilibriummoistureat25°C
`
`40
`
`50
`
`‘F0
`
`Percent relative humidity
`
`Fig. I: Equilibrium moisture content of Iiydroxypropyl nicth_vl-
`cellulose. Methocel EI5 (Dow Chemical Company, Lot No.:
`QP0502-801-E).
`
`Solutions are stable between ])I-[ 3-ll. Increasing ternperatuie
`reduces the viscosity of solutions. Hydroxypropyl niethylce|—
`lulose undergoes a reversible sol to gel
`traii1sfoi'iii:ition upon
`heating and cooling respectively. The gel point
`is 50-90°C.
`depending upon the grade of inziterial.
`Aqueous solutions are comparatively eiizyine-resistant, pro-
`viding good viscosity stability during long-term storagc.“3’
`However, aqueous solutions ai'e liable to microbial spoilage
`and should be preserved with an aiitimicrobial preservative.
`When used as a viscosity-increasing agent
`in ophthalinic
`solutions. benzalkonium chloi'ide is connnonly used for this
`purpose. Aqueous solutions may also be sterilized by
`autoclaving; the coagulated polymer must be i‘e(lispei'sed oit
`cooling by sliaking.
`I-Iydroxypropyl tnetltylcellttlose powder should be stored in at
`well-closed container. in a cool. dry. place.
`
`I2. incompatibilities
`incoinpatible with some
`I-lydioxypropyl methylcellulose is
`oxidizing agents. Since it is nonionic, ltydroxypropyl methyl-
`cellulose will not coinplcx with metallic salts and ionic oi‘gaiiics
`to Forin insoluble precipitates.
`
`13. Method of Manufacture
`
`A pui‘ilied Form oi‘ cellulose, obtained From cotton waste or
`wood pulp,
`is
`reacted with sodium hydroxide solution to
`produce a swollen alkali cellulose which is clietnically more
`reactive than untreated cellulose. The alkali cellulose is then
`treated with chloi'oinelhane aitd propylene oxide to produce
`iiictliylliydroxypropyl ethers of cellulose. The fibrous i'eaction
`product is then purified and ground to a fine, uni|‘orni powder
`or granules.
`
`14. Safety
`I-lydroxypropyl inetliylcellulose is widely used as an cxcipient
`in oral and topical pharmaceutical loi'iiiiilatioiis. It is also used
`extensively in cosmetics and Food products.
`
`H]‘(i!‘rJ.\'_l’jJi"(),')_l’i Meili_i'.-’ce!l‘iil'ri.\'e
`
`23!
`
`inethylcellulose is generally regarded as a
`Hydroxypropyl
`nontoxic and l10l‘lll‘l‘llEl|]l material although excessive oral
`coiisiiinption may have 21 laxative c|Tcci.""’ The WHO has not
`specified an acceptable daily intake for
`l1ydro.\ypropy|
`inetliylcellulose since the levels consumed were not considered
`to represent a liazard to |iea|tI1.”5’
`Lo“, (mouse, IP): 5 gikg“"‘
`LD5i. (rat. II’): 5.2 glkg
`
`15. Handling Precautions
`Observe normal [J1'BC'clLllI0l1S appropriate to the circiimstaiices
`and quantity of material handled. Hydroxypropyl methylce|-
`Iulose dust may be irritant to the eyes and eye protection is
`reconiinended. Excessive dust generation should be avoided to
`minimize the risks of explosions. Hyclroxypropyl inelltylcellu-
`lose is combustible.
`
`16. Regulatory Status
`GRAS listed. Accepted as a food additive in Europe. Inchided
`in the FDA Inactive Ingredients Guide (oplithalmic prepara-
`tions, oral capsules. suspensions. syrups and tablets.
`topical
`and vaginal preparations}. Included in nonparentei'al medi-
`cines licensed in the UK.
`
`17. Pharinacopeias
`Bi‘. Eur, Fr, Gr, It, Jpn, Neth. Poi't, Swiss and US.
`
`18. Related Substances
`
`I-lydroxyethyl Cellulose; Hydi'oxypi‘opy| Cellulose; Hydroxy-
`propyl Methylcellulose Pltthalate.
`
`19. Comments
`
`Powdered or graiitilar, surface-treated grades of liydroxypro-
`pyl methylcellulose are also available which are dispersible in
`cold water. The dissolution rate of these materials can be
`controlled by a shift in pH and they are thus iiseiul for slow-
`i'elease or en teric coated foriiitiizitiotis.
`
`20. Specific References
`l. Chowhan ZT. Role of binders in mois1ui'e—iiidiiccd hardness
`increase in coinpressed tablets and its effect on in i'i‘.'ro
`dlSll'IlCg1‘iI.l.l0l'l and dissolution. J Phiirin Sci I980; 69: I-4.
`Rowe RC. The adhesion of filiri coatings to tablet surfaces — the
`effect of some direct compression cxcipieiits and lubricants. J
`Pltarni Pliarmacol I977; 29: 723-726.
`Rowe RC. The molecular weight and niolcciilar weight
`disli'ibiition of hydroxypropyl
`inctliylcclliilosc used in the film
`coating of tablets. J Pharin Phiirinacol I980; 32: ll6~ll9.
`Banker G. Peck G. Jan 5. Piraikitikulr P. Evaluation ct‘
`hydroxypropyl cellulose and hydroxypropyl methyl cellulose as
`aqueous based film coatings. Drug Dev Ind Pliarin Will; 7: 693-
`Tlti.
`
`incchanisin oi‘
`(')k|1ainal”c A0. York I-‘. M0i5ltIl'U perineatioii
`sonic aqueous-based l'ilin coats.
`.l Pliarm Pharinacol
`I982:
`34(Si1pp|): 53F.
`Aldertnaii DA, Schulz GJ. Method of iniiking a granular. cold
`water dispcrsible coating cotnpoititioii for tablets. US Patent
`48|6298. I989.
`Patcll MK., Taste masking phiirinacctitical agents. US Patent
`49l6|6I. I990.
`Hardy JG. Kcnncrlcy JW. Taylor MJ. Wilsoii CG. Davis SS.
`Release rates from sitstained-rclcasc buccal
`tablets in titan. J
`Pharm Phairinacol I982; 34(Suppl).' 9lP.
`
`Mylan v. Qualicaps, |PR2017—OO203
`
`Mylan v. Qualicaps, IPR2017-00203
`QUALICAPS EX. 2003 - 5/7
`
`

`

`232
`
`H}=di'r2,\'_i*pi'0p_iF! Mc!t'r_vh'r'Htilo.ve
`
`Hogan JE. Hydroxypropylnxcthyrlcclltilose sustained release
`tecliliology. Drug Dev Ind Pharm I989: IS: 975-999.
`Shah AC, Britten NJ, Oianotf LS, Badalamcnti JN. Gel-matrix
`systems exhibiting bimodal controlled release for oral delivery. J
`Controlled Release 1989; 9:
`l69—l?'S_
`Wilson HC. Cuff GW. Sustained release of isomazolc from
`matrix tablets administered to dogs. J Pharm Sci I989; TB: 582-
`584.
`
`Daltl TC. Calderwood T. Bormelh A, Tt'iInble K, Piepnteicr E.
`Influence of pltysicocltentical properties of h)'dI'oxypro])yl
`melltylccllulose on naproxcn release front sustained release
`matrix tablets. J Controlled Release I990: 14:
`|—lii.
`Banker G. Peck G, Williams E. Taylor D. Piralvtitikulr P.
`Microbiological considerations of polymer solutions used in
`aqueous film coating. Drug Dev [nd Pharin [9821 8.‘ 41-5].
`Final report on the safety assessment of hydroxyethylccllulose.
`hydroxypropylcelltilosc, metltylccllulose. hydroxypropyl methyl-
`ccllulose and cellulose gum. J Am Coll Toxicol I986; 5(3):
`l~fit].
`FAOZWI-IO. Evaluation of certain food additives and contami-
`nants:
`llIirly—liftit
`report of the joint FAOIJWI-l0 expert
`committee on food additives. Tech Rep Scr Wld l-Iltlt Org
`I990: No. 789.
`I6. Sweet DV, editor. Registry of toxic effects of chemical
`substances. Cincinnati: US Department of I-lealth. I981‘.
`
`21. General References
`
`Dow Chemical Company. Technical literature: tl‘f(’ffH}t"(’f. I993.
`Doelkcr E. Cellulose derivatives. Adv Polymer Sci I993;
`IUT: I99-265.
`Malalualaris S. Karidas T, Goidas I’. Effect of particle size and sorbed
`moisture on the compression bcltavior ol‘ some hytlroxypropyl
`
`mcthylccllulosc(HPMC}polyn1ers. Int J Pharmaceutics I994; H13:
`205~2|5.
`
`Papadiniitrioa E. Buckton G, Efettlakis M. Probing the II'tL‘Cl1itI'll$l‘t'l5 of
`swelling of hydI'oxypropvlmetl1)*lcellulose matrices. Int J Pharma-
`ceutics I993: 93: 57-62.
`Influence 0|‘ liydroxypropyl
`Par-ah PV. Nayak MP. Ritschcl WA.
`methylccllulose and of manufacturing technique on in w'.'m
`performance of selected antacids. Drug Dev lutl Pharm I985: ll:
`169-185.
`Radebaugh GW. Murtha JL. Julian TN. Bondi JN. Methods for
`evaluating the puncture and shear properties of pharmaceutical
`polymeric Iilms. Int J Pliartnacculics 1988: 45: 39-46.
`Rowe RC. Materials used ill the film coating of oral dosage forms. In:
`Florence AT. editor. Critical reports on applied chemistry. volume
`6: materials used in pharmaceutical t‘orn1ul:ttion. ()x|‘ortl: lilaekivell
`Scientific I-‘ublicatious, I984: l-36.
`Seberl P. Andriauoff N. Rollel M. Elfect of gamma irradiation on
`hyttroxypropylmethylcellulosc powtlers: consequences on pltysical.
`rheological and pharmacotcchuical properties. [nt .| Phartnaceutics
`1993; 99: 3?-42.
`|9??.
`S|1in—Etsu Chemical Co Ltd. Technical literature: .r'Ih’u'fJilr:.\'(*.
`Shin-Etsu Chemical Co Ltd. Technical
`literatitrc: P»‘rar.uirrcorrt
`h).'dI'oxypt'op}'l methylccllulose. I990.
`Wan LSC. Hcug PWS. Wong LF. The effect of Iiydroxypropylmctl1yl-
`cellulose on water penetration into a matrix systexn.
`int
`J
`Pharmaceutics 1991: 73: Ill-l l6.
`
`22. Authors
`
`USA: RJ l-larwood, JL Johnson.
`
`Mylan v. Qualicaps, |PR2017—OO203
`
`Mylan v. Qualicaps, IPR2017-00203
`QUALICAPS EX. 2003 - 6/7
`
`

`

`h.=ric.\'
`
`64'}
`
`Gingili oil, 420
`Glidanls,
`Colloidal silicon dioxide, 424
`Magnesium trisilieate. 283
`Powdered cellulose, 88
`Starch, 433
`'
`Talc. SI9
`Trihasic calcium phosphate, 6]
`Ghrctd, 415
`Glucir7c.\', 289, 609, 615, 62]
`L)-Glucitol, 477
`o-(+)-Glucopyranose monohydralc, I54
`4-(ct-o-Glucopyrzmosido)-o-glucopyranosc,
`202
`05-D-GIucopyranosyl—fi—D—frtletofu ra nosidc,
`500
`o--D—G|ucopyrauosyl-I ,4—n—g1t:citol, 288
`4-0-H-D-GIUCopyl‘al‘IOS)']-,8-D-gILlC()]’))’r-
`anose, 202
`Glucose, I54
`Anhydrous, I56
`Liquid, 202
`Syrup, 202
`D-Glucose, 562
`o-(+)-Glucose monohydrate, 154
`1::-Glucuronie acid. 562
`Gluside, 415
`Glyeeridcs, semisyrtlhetic, S I 2
`Glycerin, 204
`Glycerin palmitostearale, 2| I
`Glyeerine, 204
`Glycerol, 204
`Glycerol monostearate, 209
`Se|F—en1ulsifying, 210
`Glycerol palmitostearale, 21 I
`Glycerol polyethylencglycol oxyslearatc, 371
`Glycerol polyelhylencglycol rieinoleate, 371
`Glycerol stearate, 209
`Glycerol lriztcetate, 534
`Glyeeroli monostearas 40-50, 210
`Glycerol~l~oIea1e, 207
`Glyeerolurn, 204
`Glyecryl bcltenate, 2|}
`Glyeeryl monooleate, 207
`Non—emulsifying grade, 207
`Self-emulsifying grade, 207
`Glyccryl mono—oleate, 207
`Culyceryl monopalmitatc, 209
`Glyceryl monostcn rate. 209
`Glyeeryl monostcaratc 40-50, 210
`Glyceryl palmitostearate, 2] l
`Glyceryl stearatc, 209
`Glyceryl stearate SE, 2l0
`Glyceryl lriacctate, 534
`Glyeeryl tribeltenale, 21]
`Glyeeryl tricatprylatefettprate, 299
`GIyceryl—lri-[ I2-Ilydroptystearate), 82
`Gl_t-‘cine max, 482
`Gl'_]-wire sofa, 482
`Glycofurol, 2I3
`Glyeojirrof 75, 213
`Glycoimd grades, 473, 607, 620
`G:'_t=con, 325
`Gt‘)-wort G-700, 204, 607, 620
`Glyeorr S~90, 494. 607, 620
`Gl'yc'o.rper.\'e grades, 375, 607, 620
`Glyeuronan polymer, 10
`GMS, 209
`GMS SE, 210
`Goat's thorn, 532
`Gold, 126
`Go.rs_1'pitmt !'u'r.m.'u.-H, I37
`Grain alcohol, 7
`
`(.ir7‘fl'l'l'ltL:'I(‘, 614
`Grmtulating agents.
`Acacia,
`I
`Dextrose, I54
`Gelatin, I99
`Povidone, 392
`Starch. 483
`Sucrose, 500
`Tragaeanth. 532
`Grmmli'te, 603
`Grape sugar, [54
`Green F, I27, 128
`Green SS, [28
`Grace, 325
`Gram!’ 400, 379
`Grormd G}’fJ.\‘Il'l'i|'1 1-‘G200, 603
`Gromid G_t=p.wmI Supeijfirre I-Write, 603
`Groundnut oil, 329
`Guanine, I29
`Guztr flour, 2l5
`Guar gum, 2l5
`Guethol, 184
`L-Gulo-D-lnannoglyctlronan, I0
`o--(l—-4)-L—Gu|osyluronic acid, I0. 409. 428
`Gum,
`I
`Acacia.
`1
`Arabic,
`Dragon, 532
`Guar, 215
`Hog, S33
`Talha,
`I
`Tragacanth, S32
`Gypsum, 66
`Anhydrous. 66
`Dried, 68
`
`Halite, 44]
`Haloearbon |52a, 169
`Hrtloii 72, I60
`Hard capsules, 199
`Hard (at, 512
`Hard water, 548
`Hard wax, 327
`Hrmo.-‘mi, 264, 604, 617
`HCFC 22, H9
`Heavy kaolin, 247
`Heavy liquid pelrolalum, 3I4
`Heavy magnesium ca rbonatc, 274
`Heavy magnesium oxide, 273
`l-Ieavy mineral oil, 3l4
`HEC‘, 219
`Heliudone pink CN, I27, I28
`Hei'rue.vetri.s', 4] 5
`Hexadeeanoic aeitl, 496
`lsopropyl ester, 245
`l—Metl1ylelhyl ester, 245
`l—I-lexadecanol, 99
`He:-tadecan~l-ol, 99
`u-Hexadceyl alcohol, 99
`Hexadecylic acid, 496
`Hexacleeyltrimcthylammonium bromide, 96,
`97
`Hexadccyltrimethylammonium hydroxide,
`96
`(E,E]-Hexa-2,4-dienoic acid, 470
`Potassium salt, 390
`2,4-Hcxadicnoic acid, 470
`Potassium salt, 390
`Hexallydrothymol, 304
`l, I’—Hexarnetl1ylencbis[S—(4-chloro-
`pheuyl)biguanidc], I06
`Diacetate, I08
`Diglttconatc, I09
`Dihydrochloride, 109
`
`Hcxantie acid, 447
`l,2,3,4,5.6—Hexanel1exoI, 294, 477
`HF/\ 1342!, S24
`HFC l34a. 524
`I-[PC |52a. I69
`Hr71ir'l'wt.s', 109
`Hi'br'scrtrb. 109
`llibitarre, 109
`Hibitrme rtlirrcetate, [08
`High fructose syrup, I95
`Hodug, 617
`Hark.-g DGS, 379
`Haring GMO, 207
`Honing GM S, 209
`Hmiag GMS—D, 210
`Hodrtg PEG, 355, fiI7
`Hodag POE (40) MS. 379
`Hmlrig PSMIL-4, 375
`Horlrig PSMIL-21’), 375
`Hodttg PSMO-5, 375
`Hodag PSM0-20, 375
`Hodag PSMP—20, 375
`Hodrig I-‘SMS—4'. 375
`Horkig PSMS-20, 375
`I-Ior.-‘rig PSTO-20, 375
`Haring PS TS—20, 375
`Hridug 20-S, 379
`Hodug 22-8, 379
`Horlrtg 40-S, 379
`Hodrrg 42-5, 379
`Hodrig 60~S, 379
`Hodttg 62-S, 379
`Hodtrg Hit’!-S, 379
`Hodrrg 154-3, 379
`Hodrrg 600-3, 379
`Hodrrg 602-5’, 379
`Htrdtig SML, 473
`Horfrig SMO, 473
`Hodrtg SMP, 473
`Horlrrg SMS, 473
`Hodrig SS0, 473
`Hodag STO, 473
`Hodrtg S TS, 473
`llog gum, 533
`HPMC, 229
`HPMCP, 233
`HSA, 5
`Human serum albumin. 5
`Humeetants.
`Glycerin, 204
`Propylene glycol, 40?
`Sorbitol, 477
`Triacelin, 534
`H_]'(rdcl'l, GI3
`H_1'mm‘me 7622, 30. 607
`Hl'(lJ7!l7l€ 3500, 27, 607
`I-lyriogeri, 606
`Hydex, 477, 607, 620
`Hydrated aluminum silicate, 247
`Hydrazine yellow, [33
`Hydrochloric acid, 2I7
`Concentrated, 217
`Dilute. 218
`Diluted, 218
`‘Hydrogen oxide, 546
`Hydrogenated Castor oil, 82
`I-Iyd rogeuated castor oil POE—40. 37l
`Hydrogenated Castor oil POE—60, 37!
`Hydrogenated cottonseed oil. 544
`Hydrogenated glucose s)’Wl3- 237
`Hydrogenated maltose. 233
`Hydrogenated palm oil. 544
`
`Mylan v. Qualicaps, |PR2017—OO203
`
`Mylan v. Qualicaps, IPR2017-00203
`QUALICAPS EX. 2003 - 7/7
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket